Lungenklinik Hemer Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01674738
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Lung Clinic Hemer | Lungenklinik Hemer, D-58675 Hemer, Germany

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4